Camarda Financial Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-37
| Closed | -$5K | – | 502 |
|
|
2019
Q2 | $5K | Buy |
+37
| New | +$5K | 0.01% | 210 |
|
|
2017
Q1 | – | Sell |
-19
| Closed | -$2K | – | 265 |
|
|
2016
Q4 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 231 |
|
|
2016
Q1 | – | Sell |
-1,184
| Closed | -$226K | – | 316 |
|
|
2015
Q4 | $226K | Buy |
+1,184
| New | +$226K | 0.14% | 90 |
|
|
2015
Q2 | – | Sell |
-232
| Closed | -$40K | – | 282 |
|
|
2015
Q1 | $40K | Buy |
232
+71
| +44% | +$12.2K | 0.02% | 147 |
|
|
2014
Q4 | $30K | Buy |
+161
| New | +$30K | 0.02% | 165 |
|